Amarantus

Amarantus To Present Poster on Alzheimer’s Blood Assay At 12th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

Alzheimer's News, News
Amarantus, a biotechnology company developing diagnostics in neurology and orphan drugs in neurology, ophthalmology, psychiatry and regenerative medicine, recently announced their abstract “The LymPro® Assay: A Biomarker For Alzheimer’s Disease Using Blood Samples From Clinically Diagnosed ... Read more